Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
about
A comprehensive overview of radioguided surgery using gamma detection probe technologySelumetinib-enhanced radioiodine uptake in advanced thyroid cancerA novel mechanism of sodium iodide symporter repression in differentiated thyroid cancerPreclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamidePersonalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid CancerContemporary Management of Recurrent Nodal Disease in Differentiated Thyroid CarcinomaRadioiodine Remnant Ablation: A Critical ReviewInternal radiation therapy: a neglected aspect of nuclear medicine in the molecular eraManagement of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literatureMetastatic mechanisms in follicular cell-derived thyroid cancerCurrent status and future perspectives in differentiated thyroid cancerExtended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to VemurafenibEstrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancerDisparities between male and female patients with thyroid cancers: sex difference or gender divide?2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMalignant thyroid bed mass after total thyroidectomy.A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic TargetLong-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancerAnalysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.Current concepts and future directions in differentiated thyroid cancer.Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancerComparison of the Influence on the Liver Function Between Thyroid Hormone Withdrawal and rh-TSH Before High-Dose Radioiodine Therapy in Patients with Well-Differentiated Thyroid Cancer.Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective.Distinguishing classical papillary thyroid microcancers from follicular-variant microcancersRenal metastases as the initial presentation of papillary thyroid carcinoma: A case report and literature review.Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.The Role of Central Neck Lymph Node Dissection in the Management of Papillary Thyroid Cancer99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients.The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancerEmpiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?Tc-99m radio-guided completion thyroidectomy for differentiated thyroid carcinoma.Old and new insights in the treatment of thyroid carcinoma.Clinical experience with modified Miccoli's endoscopic thyroidectomy for treatment of thyroid carcinoma in 86 cases.Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi ruleUpdate on thyroid cancer treatment.Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision.
P2860
Q21245578-8D6C3509-9CDA-44DE-90C8-A25F6E20FF87Q24596266-6AF52A2A-226F-4C2C-B04B-0D36CFF7E2F2Q24643372-1B3EDFA2-65A7-4A9D-B462-A4749E7695CFQ24647228-95BA3F4A-AFEA-4F5B-BECA-9E26D83A2E7DQ26744936-71240190-DF8F-4C09-ABFA-A186A7197A60Q26765093-BE4190A7-9B70-42FC-9093-472975FDE67AQ26784202-B0CEB97E-47B4-43E0-B224-0114E84D7E64Q26786554-E5E10230-87C0-4EB6-8E41-BB9DB9A2B52CQ26862777-15A1A20A-E521-47A0-9D93-AAFF9F3A9081Q27005646-C47002E6-254A-4215-8016-A9C4AFD8F9B8Q27024484-7118CA8A-81B9-45C5-A791-0F09385E58A0Q27853034-A591613E-06EB-43CB-9FFF-A51068F9EC8AQ28476759-7BF17930-5A1F-4C6E-B632-7B7B4E317A9BQ30319959-3654FF98-B778-4BA5-AF63-56E1D5D15AE7Q30367068-3BE299FA-B916-4603-A6B9-C8FC9A6600DBQ30449566-01250DF2-E14D-497D-849A-DF7EF73ECD1CQ33295399-7F0C0CC4-D1F6-44DB-A117-0CEDAD8F9EB1Q33565746-341D8CE1-AEC9-41A5-8C87-94F167F6A8ECQ33570297-F129B352-D49E-44E1-8458-221B78B071C8Q33587809-CD8D66D2-79D0-429A-B840-EAB61733ABC8Q33672603-39732A93-8A6B-4D3D-8265-DDFBE8C83A1FQ33677589-28C47A2D-5449-4F10-B207-E3508D2226EBQ33684552-EC90E503-DB31-428C-9342-2E8C5465A048Q33704024-B20C3CB1-1857-4952-ADD7-F5091E302623Q33704312-FACD790D-06FA-41A6-A869-F114FE51FC00Q33713784-BCAF8E66-E3C1-42F4-A6F9-86AD5F556D7AQ33740833-351013AC-5C2E-447B-BBBA-E412379BF591Q33748241-30092F89-5082-487E-B953-0F48F14059F6Q33759426-73B88BE6-706C-4B1B-BB0C-B20E382698D3Q33810411-64E3A986-2247-4E28-93FD-883CAD204443Q33844145-05A660A1-012C-49C2-8B2C-088C0F407AB8Q33973101-061BC049-9A9C-4BDF-8361-F5FA6FB5D4D2Q34039273-53B6734F-1811-4470-83E6-C8036D107111Q34107061-36FAC56D-4772-4659-9091-E8D7C1C4BBEFQ34209934-8877F080-56CE-47E4-B0F4-570EC0510E96Q34252940-E5D8DC70-641D-41D1-9025-32AAE56E26D4Q34255791-A6E51056-BC71-4088-9B4B-7CD901363407Q34281129-217D2E85-4EC7-4A68-9674-21634D4D1948Q34310219-275871EA-6E21-42F4-9905-9327E68EDA6DQ34331391-666A63D3-58C1-45BD-93B7-E1DDD19FFF29
P2860
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical review 128: Current a ...... and follicular thyroid cancer.
@ast
Clinical review 128: Current a ...... and follicular thyroid cancer.
@en
Clinical review 128: Current a ...... and follicular thyroid cancer.
@nl
type
label
Clinical review 128: Current a ...... and follicular thyroid cancer.
@ast
Clinical review 128: Current a ...... and follicular thyroid cancer.
@en
Clinical review 128: Current a ...... and follicular thyroid cancer.
@nl
prefLabel
Clinical review 128: Current a ...... and follicular thyroid cancer.
@ast
Clinical review 128: Current a ...... and follicular thyroid cancer.
@en
Clinical review 128: Current a ...... and follicular thyroid cancer.
@nl
P356
P1476
Clinical review 128: Current a ...... and follicular thyroid cancer.
@en
P2093
Mazzaferri EL
P304
P356
10.1210/JC.86.4.1447
P407
P577
2001-04-01T00:00:00Z